Chronic Idiopathic Urticaria

Dermatology
3
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
1
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Monoclonal Antibody
1100%
+ 2 programs with unclassified modality

Competitive Landscape

3 companies ranked by most advanced pipeline stage

UP
UCB PharmaBelgium - Brussels
1 program
1
LevocetirizinePhase 41 trial
Active Trials
NCT00264303Completed886Est. Jan 2007
Kiniksa Pharmaceuticals
1 program
1
KPL-716Phase 21 trial
Active Trials
NCT03858634Completed58Est. Jun 2020
Genentech
GenentechCA - Oceanside
1 program
1
omalizumabPhase 2Monoclonal Antibody1 trial
Active Trials
NCT00866788Completed90Est. Jan 2010

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
UCB PharmaLevocetirizine
Kiniksa PharmaceuticalsKPL-716
Genentechomalizumab

Clinical Trials (3)

Total enrollment: 1,034 patients across 3 trials

NCT00264303UCB PharmaLevocetirizine

CUTE (Chronic Urticaria Treatment Evaluation)

Start: Dec 2005Est. completion: Jan 2007886 patients
Phase 4Completed
NCT03858634Kiniksa PharmaceuticalsKPL-716

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

Start: May 2019Est. completion: Jun 202058 patients
Phase 2Completed
NCT00866788Genentechomalizumab

A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1)

Start: Mar 2009Est. completion: Jan 201090 patients
Phase 2Completed

Related Jobs in Dermatology

MSL/Senior MSL, Dermatology - Tampa, Florida

AbbVie
Remote
6h ago

(Senior) Außendienstmitarbeiter Dermatology (all genders) - Region Thüringen

AbbVie
Remote
6h ago

(Senior) Außendienstmitarbeiter Dermatology (all genders) - Region Thüringen

AbbVie
Remote
6h ago

Regional Sales Trainer - Dermatology (Central / West Regions)

AbbVie
Remote
7h ago

Regional Sales Trainer - Dermatology (Northeast / Southeast Regions)

AbbVie
Remote
7h ago

Delegado Especialista Ventas Dermatología (Inmunología)

AbbVie
Remote
11h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

Related Indications

Dermatitis, Atopic(42)Hidradenitis Suppurativa(30)Chronic Spontaneous Urticaria(21)Alopecia Areata(17)Hidradenitis Suppurativa (HS)(10)Vitiligo(9)Rosacea(6)Chronic Urticaria(5)Pruritus(5)Androgenetic Alopecia(5)